A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S‐1 for treatment of gastric cancer with macroscopic peritoneal metastasis

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|18|3354-3358

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.18, 2013-09, pp. : 3354-3358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 311-314

Karger

Access to resources Recommend Favorite

Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 40-46

Karger

Access to resources Recommend Favorite

A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S‐1 plus intravenous paclitaxel for serosa‐positive gastric cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 1041-1046

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I and Pharmacokinetic Study of S-1 Combined with Weekly Paclitaxel in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 414-420

Karger

Access to resources Recommend Favorite